COSMECEUTICALS printed skin market and 2. EVOLVA, in using

COSMECEUTICALS – blessing by Biotechnology.Sakshi tyagi, Dr. Vibha Gupta*Department of Biotechnology, JaypeeInstitute of Information Technology, NoidaA-10, Sector – 62, Noida, UttarPradesh-201307*Corresponding Author:ABSTRACTSinceancient times, science is the only tool on which humans have been keeping faithwhich helps humans to make their life easier and closer to their desires.With thedevelopment of science and technology the boundaries between various industrieslike biotechnology, beauty and healthcare-erode.Cosmeticcompanies use biotechnology both to discover and manufacture components ofcosmetics and to evaluate the effects of natural and synthetic compounds onskin and skin changes associated with aging. The compounds they discover anduse are termed as “cosmeceuticals”.

Cosmeceuticals- is thecombination of cosmetics and pharmaceuticals. Consumers often associate theclinically inspired ingredients in cosmeceuticals with efficacy, and they arewilling to pay a premium price for these products.The globalbeauty market is valued at approximately 300 billion dollars and is expected toclimb to 390 billion dollars by the year 2020. The demand for cosmetics isincreasing rapidly due to several factors due to which some companies havestarted looking down to new avenues in expanding their product line. L’Oreal, oneof the largest beauty and Cosmetics Company in the world, itself has twoseparate Biotech partnerships – 1.  ORGANOVO, in an attempt to enter the3D printed skin market and 2. EVOLVA, in using Genetically Modified Yeast.There are various reasons why biotechnology is booming in the beautysector.

Biotechnology is significantly more effective than traditional skincare products as stem cells have the capability of cellular regeneration.One of the most famous biotechnology products is botulinum toxin,which is commonly known by its commercial name-BOTOX. This protein is made bybacteria clostridium botulinum. Botox minimizes wrinkles byparalyzing nerve cells.Over thepast decade, cosmetic companies have invested heavily in molecular, genomic andproteomic research into what causes skin cells to age, with the hope ofpinpointing ways to interfere with that process.

The healthygrowth in cosmeceuticals is mainly being driven by an aging population acrossthe globe and by product innovation by cosmetic makers. Antiaging products arein particularly high demand. As cosmeceuticals are not regulated by the US Foodand Drug Administration (FDA), cosmetics manufacturers can avoid the hassle oftime consuming and expensive regulatory processes for obtaining approval forthese products. At the same time ,they can demand premium prices forcosmeceuticals because consumer demand for their additional health andtherapeutic benefits is strong.